Response to Cottu, Bozec, Basse, and Paoletti

Affiliations

¹ Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
² Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
³ Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT, USA.
⁴ Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru.
⁵ Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
⁶ Department of Surgery and Cancer, Imperial College London, London, UK.

Comment

Hua Zhang et al. J Natl Cancer Inst. 2021.

. 2021 Mar 1;113(3):344-345.

doi: 10.1093/jnci/djaa214.

¹ Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
² Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
³ Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT, USA.
⁴ Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru.
⁵ Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
⁶ Department of Surgery and Cancer, Imperial College London, London, UK.

No abstract available

Comment on

Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis.
Cottu P, Bozec L, Basse C, Paoletti X. Cottu P, et al. J Natl Cancer Inst. 2021 Mar 1;113(3):342-343. doi: 10.1093/jnci/djaa213. J Natl Cancer Inst. 2021. PMID: 33404622 Free PMC article. No abstract available.

1. Cottu P, Bozec L, Basse C, et al. Clinical Characteristics and Outcomes of COVID-19ãInfected Cancer Patients: A Systematic Review and Meta-Analysis. J Natl Cancer Inst. 2020; 113(3):342–343. - PMC - PubMed
1. Basse C, Diakite S, Servois V, et al. Characteristics and outcome of SARS-CoV-2 infection in cancer patients. JNCI Cancer Spectrum. 2020; doi: 10.1093/jncics/pkaa090. - PMC - PubMed
1. Saini KS, Tagliamento M, Lambertini M, et al. Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020;139:43–50. - PMC - PubMed
1. Salunke AA, Nandy K, Pathak SK, et al. Impact of COVID-19 in cancer patients on severity of disease and fatal outcomes: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(5):1431–1437. - PMC - PubMed
1. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919–1926. - PMC - PubMed